MBAI
Price
$1.13
Change
-$0.09 (-7.38%)
Updated
Jul 13 closing price
Capitalization
8.66M
20 days until earnings call
Intraday BUY SELL Signals
TWST
Price
$90.35
Change
-$0.29 (-0.32%)
Updated
Jul 13 closing price
Capitalization
5.63B
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MBAI vs TWST

MBAI vs TWST Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
MBAI vs. TWST commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBAI is a StrongBuy and TWST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (MBAI: $1.13 vs. TWST: $90.35)
Brand notoriety: MBAI and TWST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MBAI: 64% vs. TWST: 26%
Market capitalization -- MBAI: $8.66M vs. TWST: $5.63B
MBAI [@Medical Specialties] is valued at $8.66M. TWST’s [@Medical Specialties] market capitalization is $5.63B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $17.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBAI’s FA Score shows that 1 FA rating(s) are green whileTWST’s FA Score has 0 green FA rating(s).

  • MBAI’s FA Score: 1 green, 4 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, TWST is a better buy in the long-term than MBAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBAI’s TA Score shows that 6 TA indicator(s) are bullish while TWST’s TA Score has 3 bullish TA indicator(s).

  • MBAI’s TA Score: 6 bullish, 4 bearish.
  • TWST’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MBAI is a better buy in the short-term than TWST.

Price Growth

MBAI (@Medical Specialties) experienced а -2.59% price change this week, while TWST (@Medical Specialties) price change was -9.59% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.19%. For the same industry, the average monthly price growth was +9.26%, and the average quarterly price growth was +1.11%.

Reported Earning Dates

MBAI is expected to report earnings on Aug 03, 2026.

TWST is expected to report earnings on Jul 31, 2026.

Industries' Descriptions

@Medical Specialties (-3.19% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TWST($5.63B) has a higher market cap than MBAI($8.66M). TWST YTD gains are higher at: 184.836 vs. MBAI (-30.247).
MBAITWSTMBAI / TWST
Capitalization8.66M5.63B0%
EBITDAN/A-106.94M-
Gain YTD-30.247184.836-16%
P/E Ratio1.70N/A-
RevenueN/A409M-
Total CashN/A172M-
Total DebtN/A95.8M-
FUNDAMENTALS RATINGS
MBAI vs TWST: Fundamental Ratings
MBAI
TWST
OUTLOOK RATING
1..100
5783
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
6235
P/E GROWTH RATING
1..100
76100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBAI's Valuation (24) in the Medical Specialties industry is in the same range as TWST (42) in the Biotechnology industry. This means that MBAI’s stock grew similarly to TWST’s over the last 12 months.

MBAI's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as TWST (100) in the Biotechnology industry. This means that MBAI’s stock grew similarly to TWST’s over the last 12 months.

TWST's SMR Rating (97) in the Biotechnology industry is in the same range as MBAI (99) in the Medical Specialties industry. This means that TWST’s stock grew similarly to MBAI’s over the last 12 months.

TWST's Price Growth Rating (35) in the Biotechnology industry is in the same range as MBAI (62) in the Medical Specialties industry. This means that TWST’s stock grew similarly to MBAI’s over the last 12 months.

MBAI's P/E Growth Rating (76) in the Medical Specialties industry is in the same range as TWST (100) in the Biotechnology industry. This means that MBAI’s stock grew similarly to TWST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MBAITWST
RSI
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 18 days ago
78%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
MBAI
Daily Signal:
Gain/Loss:
TWST
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SOXX581.34N/A
N/A
iShares Semiconductor ETF
GGLS5.73N/A
N/A
Direxion Daily GOOGL Bear 1X ETF
BKMI26.23N/A
N/A
BNY Mellon Municipal Intermediate ETF
HMOP39.07-0.03
-0.08%
Hartford Municipal Opportunities ETF
ACVF53.97-0.46
-0.85%
American Conservative Values ETF

MBAI and

Correlation & Price change

A.I.dvisor tells us that MBAI and QTEX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBAI and QTEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBAI
1D Price
Change %
MBAI100%
-7.38%
QTEX - MBAI
29%
Poorly correlated
-8.07%
TWST - MBAI
26%
Poorly correlated
-0.31%
WRBY - MBAI
25%
Poorly correlated
-5.65%
SENS - MBAI
25%
Poorly correlated
-1.67%
MYGN - MBAI
23%
Poorly correlated
+0.51%
More